Item Type | Name |
Concept
|
B-Lymphocytes
|
Concept
|
Lymphocyte Activation
|
Concept
|
T-Lymphocytes
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Lymphocyte Count
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
T-Lymphocytes, Regulatory
|
Academic Article
|
Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1.
|
Academic Article
|
CXCL10 expressing hematopoietic-derived cells are requisite in defense against HSV-1 infection in the nervous system of CXCL10 deficient mice.
|
Academic Article
|
Cornea lymphatics drive the CD8+ T-cell response to herpes simplex virus-1.
|
Academic Article
|
Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system.
|
Academic Article
|
Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection.
|
Academic Article
|
An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3.
|
Academic Article
|
Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection.
|
Academic Article
|
Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.
|
Academic Article
|
Type I Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria.
|
Academic Article
|
Herpes simplex virus-1 infects the olfactory bulb shortly following ocular infection and exhibits a long-term inflammatory profile in the form of effector and HSV-1-specific T cells.
|
Academic Article
|
Herpes Simplex Virus 1 (HSV-1) 0?NLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
|
Academic Article
|
Unforeseen consequences of IL-12 expression in the eye of GFAP-IL12 transgenic mice following herpes simplex virus type 1 infection.
|
Academic Article
|
The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.
|
Academic Article
|
CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection.
|
Academic Article
|
Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection.
|
Academic Article
|
Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection.
|
Academic Article
|
CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.
|
Academic Article
|
PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection.
|
Academic Article
|
Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.
|
Academic Article
|
Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta.
|
Academic Article
|
The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.
|
Academic Article
|
Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.
|
Academic Article
|
CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system.
|
Academic Article
|
Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.
|
Academic Article
|
CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.
|
Academic Article
|
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
|
Academic Article
|
IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.
|
Academic Article
|
Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNa/ß Defense Pathways.
|
Academic Article
|
Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection.
|
Grant
|
NEUROIMMUNOLOGY OF HSV-1 REACTIVATION
|
Academic Article
|
Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0?NLS vaccine against ocular HSV-1 challenge.
|
Academic Article
|
Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0?NLS, against Herpes Simplex Virus 1.
|
Academic Article
|
HSV-1 0?NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition.
|
Academic Article
|
Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2+CD115+CD206+ macrophage infiltration following ocular HSV-1 infection of mice.
|